FDA Approves Reformulated Ranitidine Following Comprehensive Safety Review
Published on November 25, 2025 at 01:41AM by Drugs.com - Daily MedNews
November 24, 2025 -- Today, the U.S. Food and Drug Administration approved reformulated ranitidine tablets, marking the return of this important acid-reducing medication to the U.S. market after a five-year absence. The approval follows extensive...
Read the original article here: https://www.drugs.com/news/fda-approves-reformulated-ranitidine-following-comprehensive-safety-review-127712.html